Surveys - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PharmTech Poll
Poll archive button
FDA recently outlined six steps the agency will take to increase enforcement of its regulations. Are these steps:
What the agency needs to achieve its mission of improving public heath.:
55%
Not going far enough to protect consumers.:
19%
Unnecessary—FDA's processes work fine as is.:
25%
Have More to say? Send Feedback to PharmTech Polls
Other Surveys
Pharmaceutical business challenges
Manufacturing challenges
Continuous manufacturing
High potency processing
US Drug Quality and Security Act
Operational Excellence
Job security
QbD in sterile manufacturing
Drug Delivery Types
Anticounterfeiting
Social Media Tools
Threats to production
Utility of Solid-Dosage Equipment, Process Control
Application of QbD
Benefit of Applying QbD Principles
INTERPHEX 2013
Reputation of the Pharma Industry
Biosimilars
PAT Advances
Regulatory Enforcement
Industry Changes
Tablet Splitting
Trade Shows
Patent Cliff
FDA confidentiality
Preventing counterfeiting
European Pharmacovigilance Activities
Generic Drug User Fees Amendments of 2012
European Legislation
Drug Settlements
Emerging Markets
Energy Efficiency
Affordable Care Act
Drug Shortages
Transparency
Significant changes
Quality Management
Analytical equipment
DTC Advertising
Biologics Manufacturing
Powder properties
Sterile manufacturing
Social Media
API Manufacturing
Lyophilization Advances
Injection technologies
Oral drug delivery
Generic-Drug User Fees
Solid Dosage Innovation
Small-Molecule API Outsourcing
USP Monographs
Anticounterfeiting Solutions
FDA's Enforcement Strategy
Quality by Design and APIs
Outsourcing Biologics
FDA Biosimilars Pathway
Highly potent APIs
Biosimilars
Emerging markets
Strategies for Emerging Markets
Atypical actives
Shared audits
Continuous processing
Carbon Footprints
Immediate-release drug delivery
QbD and CMC
INTERPHEX 2011
FDA Transparency
Tableting equipment
Outsourcing Levels
FDA Recalls
Granulation Techniques
Pharma Forecast for 2011
Needleless devices
Trade Show Attendance
Regulation of excipients
Generic-Drug User Fees
Cleanroom Challenges
Small-Molecule Outsourcing
Pharma packaging
Recall News
Single-use technologies
Pay-to-Delay
Outsourcing concerns
Outsourcing
Green Manufacturing Efforts
Biosimilars: Threat or Opportunity?
Expanding FDA's Power
Anticounterfeiting solutions
Novel Excipients
Tablet manufacture
Equipment Purchasing
Healthcare Reform and Pharma
PharmTech Poll: Recession
Ingredient Suppliers
FDA Spending
PharmTech Poll: CMO Market
PharmTech Poll: Lyophilization
PharmTech Poll: Pharma's Economic Recovery
PharmTech Poll: 2010 M&As

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
26%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here